Company page

Candel Therapeutics, Inc.

Candel Therapeutics, Inc. (ticker: CADL) is a public company operating in the American market, with a market capitalization of approximately $700.5 million. The company focuses on developing innovative therapies for cancer treatment. Candel is committed to advancing its pipeline of therapeutics to improve patient outcomes.